We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+40.55%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$107M
AUM Growth
-$112M
Cap. Flow
-$120M
Cap. Flow %
-112.09%
Top 10 Hldgs %
43.77%
Holding
170
New
58
Increased
1
Reduced
21
Closed
89

Top Buys

Rank Stock Value
1
CLVT icon
Clarivate
CLVT
+$7.34M
2
PFGC icon
Performance Food Group
PFGC
+$7.09M
3
DT icon
Dynatrace
DT
+$5.24M
4
PHR icon
Phreesia
PHR
+$4.66M
5
ARCE
Arco Platform Limited Class A Common Shares
ARCE
+$4.24M

Top Sells

Rank Stock Value
1
INVH icon
Invitation Homes
INVH
+$12.6M
2
VER
VEREIT, Inc.
VER
+$10M
3
OPTU
Optimum Communications Inc
OPTU
+$8.46M
4
KHC icon
Kraft Heinz
KHC
+$7.82M
5
STAG icon
STAG Industrial
STAG
+$7.08M

Sector Composition

Rank Sector Weight
1 Technology 27.04%
2 Healthcare 25.93%
3 Consumer Staples 12.48%
4 Real Estate 6.92%
5 Energy 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRWD icon
26
CrowdStrike
CRWD
$218B
$1.5M 1.39%
+120,000
New +$1.57M
CNST
27
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$1.42M 1.33%
+30,200
New +$872K
CDTX
28
DELISTED
Cidara Therapeutics
CDTX
$1.42M 1.32%
18,455
– –
KIDS icon
29
OrthoPediatrics
KIDS
$595M
$1.41M 1.31%
+30,000
New +$1.16M
FSRVU
30
DELISTED
FinServ Acquisition Corp. Unit, 1 Com, 1/2 Wt.
FSRVU
$1.39M 1.3%
+135,938
New +$1.37M
RVNC
31
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.38M 1.29%
+85,000
New +$1.32M
ACEL icon
32
Accel Entertainment
ACEL
$987M
$1.35M 1.25%
+107,748
New +$1.17M
XRN
33
Chiron Real Estate Inc
XRN
$477M
$1.32M 1.23%
+20,000
New +$1.26M
VRRM icon
34
Verra Mobility
VRRM
$744M
$1.22M 1.14%
87,500
-157,065
-64% -$2.25M
ELF icon
35
e.l.f. Beauty
ELF
$5.81B
$1.21M 1.13%
+75,000
New +$1.25M
LVGO
36
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$1.13M 1.05%
+45,000
New +$1.08M
TUFN
37
DELISTED
Tufin Software Technologies Ltd.
TUFN
$1.05M 0.98%
+60,000
New +$1.02M
SRTA
38
Strata Critical Medical Inc
SRTA
$512M
$1.05M 0.98%
+106,524
New +$1.04M
ARDX icon
39
Ardelyx
ARDX
$997M
$1.01M 0.94%
+134,500
New +$817K
RCKT icon
40
Rocket Pharmaceuticals
RCKT
$394M
$951K 0.89%
+41,800
New +$698K
TPST icon
41
Tempest Therapeutics
TPST
$14.6M
$945K 0.88%
+719
New +$1.01M
AER icon
42
AerCap
AER
$23.8B
$922K 0.86%
+15,000
New +$882K
AUPH icon
43
Aurinia Pharmaceuticals
AUPH
$2.11B
$912K 0.85%
+45,000
New +$415K
NJR icon
44
New Jersey Resources
NJR
$5.58B
$891K 0.83%
+20,000
New +$864K
FSLY icon
45
Fastly Inc
FSLY
$3.66B
$746K 0.69%
+37,175
New +$784K
DFNS.U
46
DELISTED
LGL Systems Acquisition Corp. Units
DFNS.U
$693K 0.65%
+67,969
New +$686K
MAPS
47
DELISTED
WM TECHNOLOGY INC A
MAPS
$633K 0.59%
+63,914
New +$631K
BILL icon
48
BILL Holdings
BILL
$4.78B
$609K 0.57%
+16,000
New +$608K
ORGO icon
49
Organogenesis Holdings
ORGO
$239M
$557K 0.52%
115,818
+98,716
+577% +$626K
THBRW
50
DELISTED
Thunder Bridge Acquisition II, Ltd. Warrants
THBRW
$424K 0.39%
+42,610
New +$37.9K
1
2
3 4 5

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, Monashee Investment Management held 170 positions worth $107M, down 51% from $219M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Monashee Investment Management withdrew a net $120M in Q4 2019, closing 89 positions and reducing 21 holdings. Its most notable exit was Invitation Homes, an estimated $12.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 8.9% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Monashee Investment Management opened a new position in Clarivate worth $7.33M.

  • Monashee Investment Management's largest Q4 2019 buy was Clarivate: 436,000 shares worth $7.33M.
  • Monashee Investment Management added most to Organogenesis Holdings in Q4 2019, an estimated $626K increase.
  • Monashee Investment Management's biggest Q4 2019 reduction was Plymouth Industrial REIT, cutting an estimated $4.26M.
  • Monashee Investment Management fully exited Invitation Homes in Q4 2019, selling an estimated $12.6M.
  • Monashee Investment Management's ten largest holdings make up 44% of its $107M portfolio in Q4 2019.
  • Monashee Investment Management opened 58 new positions and closed 89 in Q4 2019.
  • Monashee Investment Management's portfolio value fell 51% quarter-over-quarter to $107M.

Based on Monashee Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.